FDA moves to real-time clinical trial patient monitoring, faster drug review
The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.
Apr 29, 2026
0
4
Immune System Diseases: News and Research on Lymphoma, Mantle-Cell
MeSH tree: C20.683.515.761.480.525
Hidden complexity in blood cancer may hold key to better treatments
Researchers at Karolinska Institutet have discovered that mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer, is already highly diverse at the time of diagnosis and continues to evolve in unique ways in ...
Aug 27, 2025
0
15
How lymphoma rewires the human genome
Translocations are chromosomal "cut and paste" errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but aggressive subtype diagnosed ...
Aug 21, 2025
0
61
What is mantle cell lymphoma? The 'rare and fast-moving' cancer explained
Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma.
May 31, 2025
0
30
Treatment method does not improve survival for mantle cell lymphoma patients, clinical trial shows
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant (ASCT) for patients with mantle cell lymphoma (MCL) in remission following their initial treatment. ...
Dec 10, 2024
0
21
Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease
Autologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual disease (uMRD), according to a study to ...
Dec 6, 2024
0
20
New immunotherapy shows complete responses in mantle cell lymphoma
Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial.
Oct 7, 2024
0
72
FDA approves CAR T cell treatment for resistant mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatment appears to be successful, the cancer often returns and is difficult to cure.
Aug 2, 2024
0
54
Lymphoma patients at high risk of infections after diagnosis
Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala University shows that these patients are more vulnerable to other diseases and that the risk of infection for this type of patient should ...
Jul 8, 2024
0
31
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.
Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels the ...
Mar 16, 2024
0
82
